Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
- 17 March 2008
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (3) , 273-279
- https://doi.org/10.1016/j.nucmedbio.2007.11.012
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxiaDalton Transactions, 2007
- Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSMNuclear Medicine and Biology, 2005
- [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumorsNuclear Medicine and Biology, 2003
- Going malignant: the hypoxia‐cancer connection in the prostateBioEssays, 2002
- Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationshipsJBIC Journal of Biological Inorganic Chemistry, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Efficient production of high specific activity 64Cu using a biomedical cyclotronNuclear Medicine and Biology, 1997
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Nitroimidazoles and imaging hypoxiaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- The action of radium on cancer cells. II.—Some factors determining the susceptibility of cancer cells to radiumProceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1933